Glioblastoma is resistant to the chemotherapeutic molecule temozolomide (TMZ) by expression of O6-methylguanine-DNA methyltransferase (MGMT), despite TMZ having BBB-penetrative properties. This evidence concerns the gene MGMT and glioblastoma.